Active Ingredient(s):Crisaborole FDA Approved: * December 14, 2016 Pharm Company: *ANACOR PHARMS INC Category:Skin Care
Crisaborole, sold under the brand name Eucrisa among others, is a nonsteroidal topical medication used for the treatment of mild-to-moderate atopic dermatitis (eczema) in adults and children.
The most common side effects are reactions at the application site (including burning or stinging).
Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor, although its specific mechanism of action in atopic dermatitis is not kno...
* May have multiple approval dates, manufacturers, or labelers.